Sinobiomed Engages Financial Advisor for Strategic Investment and Mergers and Acquisitions Advisory

NBC News Clone summarizes the latest on: Wbna39034722 - Breaking News | NBC News Clone. This article is rewritten and presented in a simplified tone for a better reader experience.

HONG KONG, Sept. 7, 2010 (GLOBE NEWSWIRE) -- The Board of Directors of Sinobiomed Inc. ("Sinobiomed", or "the Company") (Pink Sheets:SOBM) is pleased to announce that Bay2Peak S.A. www.bay2peak.com has recently been engaged as financial advisor to the Company.

HONG KONG, Sept. 7, 2010 (GLOBE NEWSWIRE) -- The Board of Directors of Sinobiomed Inc. ("Sinobiomed", or "the Company") (Pink Sheets:SOBM) is pleased to announce that Bay2Peak S.A. has recently been engaged as financial advisor to the Company.

Bay2Peak, S.A. is an investment management and financial advisory firm with offices in San Francisco, California, Hong Kong S.A.R. and Shanghai China. Bay2Peak has a specific focus on growth-stage companies, based in China or Southeast Asia, and provides expertise on cross-border partnerships, direct investment, mergers and acquisitions, financings and strategic advisory.

FORWARD LOOKING STATEMENTS This news release may include "forward-looking statements" regarding Sinobiomed, and its subsidiaries, business and project plans. Such forward looking statements are within the meaning of Section 27A of the Securities Act of 1933, as amended, and section 21E of the United States Securities and Exchange Act of 1934, as amended, and are intended to be covered by the safe harbor created by such sections. Where Sinobiomed expresses or implies an expectation or belief as to future events or results, such expectation or belief is believed to have a reasonable basis. However, forward-looking statements are subject to risks, uncertainties and other factors, which could cause actual results to differ materially from future results expressed, projected or implied by such forward-looking statements. Sinobiomed does not undertake any obligation to update any forward looking statement, except as required under applicable law.

CONTACT: Sinobiomed Inc. Investor Relations Intl: +86 136 0191 6614 U.S.: +1 415 830 6210 info@bay2peak.com Room 4304, 43/F China Resources Building 26 Harbour Road Wan Chai Hong Kong
×
AdBlock Detected!
Please disable it to support our content.

Related Articles

Donald Trump Presidency Updates - Politics and Government | NBC News Clone | Inflation Rates 2025 Analysis - Business and Economy | NBC News Clone | Latest Vaccine Developments - Health and Medicine | NBC News Clone | Ukraine Russia Conflict Updates - World News | NBC News Clone | Openai Chatgpt News - Technology and Innovation | NBC News Clone | 2024 Paris Games Highlights - Sports and Recreation | NBC News Clone | Extreme Weather Events - Weather and Climate | NBC News Clone | Hollywood Updates - Entertainment and Celebrity | NBC News Clone | Government Transparency - Investigations and Analysis | NBC News Clone | Community Stories - Local News and Communities | NBC News Clone